Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 27, Issue suppl_5, Pages v28-v37
Publisher
Oxford University Press (OUP)
Online
2017-02-04
DOI
10.1093/annonc/mdw324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Awareness of Tract Seeding With Endoscopic Ultrasound Tissue Acquisition in Perihilar Cholangiocarcinoma
- (2015) Nataliya Razumilava et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis
- (2015) D.P. Al-Adra et al. EJSO
- SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
- (2015) Edgar Ben-Josef et al. JOURNAL OF CLINICAL ONCOLOGY
- Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
- (2015) Juan W Valle et al. LANCET ONCOLOGY
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Second-line chemotherapy in advanced biliary cancer: a systematic review
- (2014) A. Lamarca et al. ANNALS OF ONCOLOGY
- Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma
- (2014) N. Matsumoto et al. BRITISH JOURNAL OF SURGERY
- Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review
- (2014) Martha B. Pitman et al. CANCER CYTOPATHOLOGY
- Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
- (2014) M. Moehler et al. EUROPEAN JOURNAL OF CANCER
- Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised study
- (2014) Jean-Marc Phelip et al. EUROPEAN JOURNAL OF CANCER
- Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
- (2014) David Malka et al. LANCET ONCOLOGY
- Distal Cholangiocarcinoma
- (2014) Paxton V. Dickson et al. SURGICAL CLINICS OF NORTH AMERICA
- Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
- (2013) J. W. Valle et al. ANNALS OF ONCOLOGY
- Cholangiocarcinoma among offset colour proof-printing workers exposed to 1,2-dichloropropane and/or dichloromethane
- (2013) Shinji Kumagai et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Hilar Cholangiocarcinoma: Value of Adding DW Imaging to Gadoxetic Acid–enhanced MR Imaging with MR Cholangiopancreatography for Preoperative Evaluation
- (2013) Min Jung Park et al. RADIOLOGY
- Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma
- (2012) H Nordenstedt et al. BRITISH JOURNAL OF CANCER
- Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
- (2012) Anne M. Horgan et al. JOURNAL OF CLINICAL ONCOLOGY
- Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
- (2012) William C. Palmer et al. JOURNAL OF HEPATOLOGY
- Accurate Staging for Gallbladder Cancer
- (2011) Hiromichi Ito et al. ANNALS OF SURGERY
- Risk factors for cholangiocarcinoma
- (2011) Gia L. Tyson et al. HEPATOLOGY
- Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
- (2011) Mechteld C. de Jong et al. JOURNAL OF CLINICAL ONCOLOGY
- Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
- (2011) Shahid A. Khan et al. JOURNAL OF HEPATOLOGY
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
- (2010) T Okusaka et al. BRITISH JOURNAL OF CANCER
- Gallbladder cancer: Incidence and survival in a high-risk area of Chile
- (2010) Enriqueta Bertran et al. INTERNATIONAL JOURNAL OF CANCER
- Best Supportive Care Compared With Chemotherapy for Unresectable Gall Bladder Cancer: A Randomized Controlled Study
- (2010) Atul Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
- (2010) Birgit Gruenberger et al. LANCET ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results
- (2009) Clifton David Fuller et al. RADIOTHERAPY AND ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search